Quarterly ResultMay 7, 2026, 04:15 PM
McKesson Q4 Adj. EPS $11.69, FY26 Adj. EPS $39.11; $7.7B Buyback Auth.
AI Summary
McKesson Corporation reported strong preliminary results for Q4 and full fiscal year ended March 31, 2026, with consolidated revenues increasing 6% to $96.3 billion in Q4 and 12% to $403.4 billion for the full year. Adjusted diluted EPS rose 16% to $11.69 for Q4 and 18% to $39.11 for the full year, exceeding long-range targets. The company also announced a $5.0 billion increase to its share repurchase program, bringing the total authorization to $7.7 billion, and provided fiscal 2027 Adjusted EPS guidance of $43.80 to $44.60.
Key Highlights
- Board approved $5.0B increase to share repurchase, total $7.7B authorized.
- Q4 FY26 consolidated revenues increased 6% to $96.3 billion.
- Q4 FY26 Adjusted diluted EPS rose 16% to $11.69.
- Full Year FY26 Adjusted diluted EPS increased 18% to $39.11.
- Fiscal 2027 Adjusted EPS guidance set at $43.80 to $44.60.
- Completed sale of Norway retail and distribution businesses.
- Apollo Global to acquire 13% minority stake in Medical-Surgical Solutions.